1. Home
  2. TMDX vs EEFT Comparison

TMDX vs EEFT Comparison

Compare TMDX & EEFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • EEFT
  • Stock Information
  • Founded
  • TMDX 1998
  • EEFT 1994
  • Country
  • TMDX United States
  • EEFT United States
  • Employees
  • TMDX N/A
  • EEFT N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • EEFT EDP Services
  • Sector
  • TMDX Health Care
  • EEFT Technology
  • Exchange
  • TMDX Nasdaq
  • EEFT Nasdaq
  • Market Cap
  • TMDX 4.0B
  • EEFT 3.5B
  • IPO Year
  • TMDX 2019
  • EEFT 1997
  • Fundamental
  • Price
  • TMDX $119.03
  • EEFT $71.89
  • Analyst Decision
  • TMDX Buy
  • EEFT Strong Buy
  • Analyst Count
  • TMDX 11
  • EEFT 5
  • Target Price
  • TMDX $130.73
  • EEFT $117.60
  • AVG Volume (30 Days)
  • TMDX 1.1M
  • EEFT 1.0M
  • Earning Date
  • TMDX 10-29-2025
  • EEFT 10-22-2025
  • Dividend Yield
  • TMDX N/A
  • EEFT N/A
  • EPS Growth
  • TMDX 170.70
  • EEFT N/A
  • EPS
  • TMDX 2.54
  • EEFT 6.78
  • Revenue
  • TMDX $566,354,000.00
  • EEFT $4,182,800,000.00
  • Revenue This Year
  • TMDX $38.84
  • EEFT $9.05
  • Revenue Next Year
  • TMDX $20.46
  • EEFT $7.49
  • P/E Ratio
  • TMDX $46.99
  • EEFT $10.67
  • Revenue Growth
  • TMDX 41.20
  • EEFT 7.25
  • 52 Week Low
  • TMDX $55.00
  • EEFT $71.35
  • 52 Week High
  • TMDX $145.50
  • EEFT $114.25
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 44.82
  • EEFT 20.13
  • Support Level
  • TMDX $119.20
  • EEFT $85.33
  • Resistance Level
  • TMDX $128.09
  • EEFT $74.32
  • Average True Range (ATR)
  • TMDX 7.95
  • EEFT 2.29
  • MACD
  • TMDX -0.93
  • EEFT -0.87
  • Stochastic Oscillator
  • TMDX 12.28
  • EEFT 2.28

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About EEFT Euronet Worldwide Inc.

Euronet Worldwide Inc is a provider of electronic financial transaction solutions. It offers payment and transaction processing and distribution solutions to financial institutions, retailers, service providers, and individual consumers. The company's product offerings include comprehensive ATM, POS, card outsourcing, card issuing and merchant acquiring services, software solutions, money transfer services, etc. Its reportable operating segments are EFT Processing, epay, and Money Transfer. Maximum revenue is derived from its Money Transfer segment, which provides money transfer services across the world under the brand names Ria, AFEX, IME, and xe. Geographically, the company generates maximum revenue from the United States, followed by Germany, India, France, Greece, and other regions.

Share on Social Networks: